Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Forsyth

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Thrombosis and Haemostasis|January 5, 2002
Collection and transport of samples for laboratory testing in von Willebrand's disease (VWD): time for a reappraisal?E J Favaloro, S C Nair, C J Forsyth
The Journal of Organic Chemistry|June 30, 2001
Expedient access to the okadaic acid architecture: a novel synthesis of the C1-C27 domainA B Dounay, R A Urbanek, V A Frydrychowski, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2001
Importance of the C28-C38 hydrophobic domain of okadaic acid for potent inhibition of protein serine-threonine phosphatases 1 and 2AV A Frydrychowski, R A Urbanek, A B Dounay, et al.
Ernst Schering Research Foundation Workshop|November 15, 2000
Biotherapeutic potential and synthesis of okadaic acidC J Forsyth, A B Dounay, S F Sabes, et al.
Journal of the American College of Cardiology|October 1, 1995
Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young menM R Adams, C J Forsyth, W Jessup, et al.
Bone Marrow Transplantation|February 1, 1996
Thalidomide responsive chronic pulmonary GVHDC J Forsyth, P D Cremer, P Torzillo, et al.
Science (New York, N.Y.)|February 10, 1995
Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinasesF M Uckun, W E Evans, C J Forsyth, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Thrombosis and Haemostasis|January 5, 2002
Collection and transport of samples for laboratory testing in von Willebrand's disease (VWD): time for a reappraisal?E J Favaloro, S C Nair, C J Forsyth
The Journal of Organic Chemistry|June 30, 2001
Expedient access to the okadaic acid architecture: a novel synthesis of the C1-C27 domainA B Dounay, R A Urbanek, V A Frydrychowski, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2001
Importance of the C28-C38 hydrophobic domain of okadaic acid for potent inhibition of protein serine-threonine phosphatases 1 and 2AV A Frydrychowski, R A Urbanek, A B Dounay, et al.
Ernst Schering Research Foundation Workshop|November 15, 2000
Biotherapeutic potential and synthesis of okadaic acidC J Forsyth, A B Dounay, S F Sabes, et al.
Journal of the American College of Cardiology|October 1, 1995
Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young menM R Adams, C J Forsyth, W Jessup, et al.
Bone Marrow Transplantation|February 1, 1996
Thalidomide responsive chronic pulmonary GVHDC J Forsyth, P D Cremer, P Torzillo, et al.
Science (New York, N.Y.)|February 10, 1995
Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinasesF M Uckun, W E Evans, C J Forsyth, et al.
Pageof 2